Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text |  PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_31_2023 |
4,146 | 84,176 | 88,322 |
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_39_2023 |
1,529 | 86,102 | 87,631 |
CommentaryStatus of research and publication in IndiaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_29_2023 |
2,849 | 74,029 | 76,878 |
EditorialEczema and skin allergy-focus on researchFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_29_2024 |
1,669 | 60,807 | 62,476 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_52_2023 |
3,627 | 44,743 | 48,370 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_45_2023 |
3,868 | 41,273 | 45,141 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_15_2024 |
2,317 | 39,550 | 41,867 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2023 |
2,857 | 37,861 | 40,718 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_14_2024 |
2,028 | 35,908 | 37,936 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_26_2023 |
3,803 | 25,867 | 29,670 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_6_2024 |
3,600 | 21,602 | 25,202 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_3_2024 |
2,971 | 19,896 | 22,867 |
Case ReportA novel pitch against the itchFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_13_2024 |
3,059 | 19,596 | 22,655 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_44_2023 |
7,044 | 15,323 | 22,367 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_3_2021 |
13,749 | 3,826 | 17,575 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_19_2024 |
2,847 | 14,480 | 17,327 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_9_2024 |
4,895 | 12,243 | 17,138 |
ImageGiant fixed drug eruptionFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_47_2023 |
2,507 | 14,333 | 16,840 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_5_2021 |
11,146 | 3,263 | 14,409 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_1_2024 |
2,005 | 11,903 | 13,908 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_42_2023 |
1,857 | 12,036 | 13,893 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_48_2023 |
3,327 | 9,631 | 12,958 |
SymposiumCutaneous photobiologyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_11_2024 |
2,943 | 9,633 | 12,576 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2024 |
4,118 | 8,108 | 12,226 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_50_2023 |
5,104 | 6,931 | 12,035 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_4_2024 |
2,193 | 9,825 | 12,018 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_5_2024 |
3,287 | 8,654 | 11,941 |
SymposiumPolymorphous light eruptionsFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_8_2024 |
3,114 | 8,824 | 11,938 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_28_2023 |
2,750 | 9,037 | 11,787 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_7_2021 |
8,222 | 3,305 | 11,527 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_25_2023 |
1,892 | 9,449 | 11,341 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_16_2024 |
4,623 | 6,674 | 11,297 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_51_2023 |
2,881 | 8,232 | 11,113 |
SymposiumChronic actinic dermatitisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_10_2024 |
3,388 | 7,618 | 11,006 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_31_2024 |
1,718 | 9,208 | 10,926 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_30_2023 |
2,230 | 7,903 | 10,133 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_21_2022 |
1,906 | 7,675 | 9,581 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_21_2024 |
1,661 | 7,672 | 9,333 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_41_2024 |
1,563 | 7,416 | 8,979 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_11_2021 |
4,286 | 3,665 | 7,951 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_14_2023 |
4,964 | 2,591 | 7,555 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_20_2024 |
2,005 | 5,379 | 7,384 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_22_2022 |
3,919 | 3,251 | 7,170 |
Conference ReportUpcoming dermatology conferences 2025Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_2_2025 |
5,084 | 1,716 | 6,800 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_12_2021 |
4,479 | 2,265 | 6,744 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_41_2023 |
3,204 | 3,500 | 6,704 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_20_2023 |
4,483 | 1,988 | 6,471 |
ObituaryObituary – Professor Marcus Maurer (1966–2024)Full text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_47_2024 |
4,441 | 1,975 | 6,416 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_4_2022 |
3,802 | 2,565 | 6,367 |
Review ArticleAssessing eczema severity: A comprehensive review of scoring systemsFull text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_50_2024 |
4,303 | 1,472 | 5,775 |
